On October 27, 2025, Eli Lilly announced a partnership with NBA legend Shaquille O'Neal to launch a nationwide campaign raising awareness about moderate-to-severe obstructive sleep apnea (OSA), targeting the 24 million affected U.S. adults, many of whom are overweight or living with obesity[3]. The initiative aims to educate the public and encourage diagnosis, but there is no indication this news has moved the stock significantly. LLY shares are down 0.48% to $821.48 in live trading, underperforming the broader market rally (S&P 500 +1.01%, NASDAQ +1.72%). The modest decline suggests LLY is not reacting strongly to today's news and may be influenced more by broader market sentiment or sector rotation rather than company-specific developments.